» Articles » PMID: 16817970

Abnormal X: Autosome Ratio, but Normal X Chromosome Inactivation in Human Triploid Cultures

Overview
Journal BMC Genet
Publisher Biomed Central
Date 2006 Jul 5
PMID 16817970
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Background: X chromosome inactivation (XCI) is that aspect of mammalian dosage compensation that brings about equivalence of X-linked gene expression between females and males by inactivating one of the two X chromosomes (Xi) in normal female cells, leaving them with a single active X (Xa) as in male cells. In cells with more than two X's, but a diploid autosomal complement, all X's but one, Xa, are inactivated. This phenomenon is commonly thought to suggest 1) that normal development requires a ratio of one Xa per diploid autosomal set, and 2) that an early event in XCI is the marking of one X to be active, with remaining X's becoming inactivated by default.

Results: Triploids provide a test of these ideas because the ratio of one Xa per diploid autosomal set cannot be achieved, yet this abnormal ratio should not necessarily affect the one-Xa choice mechanism for XCI. Previous studies of XCI patterns in murine triploids support the single-Xa model, but human triploids mostly have two-Xa cells, whether they are XXX or XXY. The XCI patterns we observe in fibroblast cultures from different XXX human triploids suggest that the two-Xa pattern of XCI is selected for, and may have resulted from rare segregation errors or Xi reactivation.

Conclusion: The initial X inactivation pattern in human triploids, therefore, is likely to resemble the pattern that predominates in murine triploids, i.e., a single Xa, with the remaining X's inactive. Furthermore, our studies of XIST RNA accumulation and promoter methylation suggest that the basic features of XCI are normal in triploids despite the abnormal X:autosome ratio.

Citing Articles

Silencing XIST on the future active X: Searching human and bovine preimplantation embryos for the repressor.

Aksit M, Yu B, Roelen B, Migeon B Eur J Hum Genet. 2022; 32(4):399-406.

PMID: 35585273 PMC: 10999447. DOI: 10.1038/s41431-022-01115-9.


Ovarian follicles of young patients with Turner's syndrome contain normal oocytes but monosomic 45,X granulosa cells.

Peek R, Schleedoorn M, Smeets D, van de Zande G, Groenman F, Braat D Hum Reprod. 2019; 34(9):1686-1696.

PMID: 31398245 PMC: 6736193. DOI: 10.1093/humrep/dez135.


Embryonic loss of human females with partial trisomy 19 identifies region critical for the single active X.

Migeon B, Beer M, Bjornsson H PLoS One. 2017; 12(4):e0170403.

PMID: 28403217 PMC: 5389809. DOI: 10.1371/journal.pone.0170403.


A self-enhanced transport mechanism through long noncoding RNAs for X chromosome inactivation.

Li C, Hong T, Webb C, Karner H, Sun S, Nie Q Sci Rep. 2016; 6:31517.

PMID: 27527711 PMC: 4985753. DOI: 10.1038/srep31517.


Jpx RNA activates Xist by evicting CTCF.

Sun S, Del Rosario B, Szanto A, Ogawa Y, Jeon Y, Lee J Cell. 2013; 153(7):1537-51.

PMID: 23791181 PMC: 3777401. DOI: 10.1016/j.cell.2013.05.028.


References
1.
Morey C, Navarro P, Debrand E, Avner P, Rougeulle C, Clerc P . The region 3' to Xist mediates X chromosome counting and H3 Lys-4 dimethylation within the Xist gene. EMBO J. 2004; 23(3):594-604. PMC: 1271805. DOI: 10.1038/sj.emboj.7600071. View

2.
Nguyen D, Disteche C . Dosage compensation of the active X chromosome in mammals. Nat Genet. 2005; 38(1):47-53. DOI: 10.1038/ng1705. View

3.
Heard E . Recent advances in X-chromosome inactivation. Curr Opin Cell Biol. 2004; 16(3):247-55. DOI: 10.1016/j.ceb.2004.03.005. View

4.
Kawakami T, Zhang C, Taniguchi T, Kim C, Okada Y, Sugihara H . Characterization of loss-of-inactive X in Klinefelter syndrome and female-derived cancer cells. Oncogene. 2004; 23(36):6163-9. DOI: 10.1038/sj.onc.1207808. View

5.
Mukherjee A, Beermann W . Synthesis of ribonucleic acid by the X-chromosomes of Drosophila melanogaster and the problem of dosage compensation. Nature. 1965; 207(998):785-6. DOI: 10.1038/207785a0. View